Biosimilar Red Tape Elimination Act
Summary
Biosimilar Red Tape Elimination Act This bill removes and otherwise modifies certain requirements related to the approval of biosimilars, such as prohibiting the Food and Drug Administration from requiring studies that assess the risks of switching between the biosimilar and the reference biologic.
Bill status
in committee
1 of 4 stages cleared
Introduction
Nov 2022
Committee Review
Floor Vote
President
Introduced Nov 17, 2022
Last action Nov 17, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Nov 17, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Nov 17, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mike Lee
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 6
Scope: US
Hi! I can help you understand S 6. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline